Generic Drug Shortages costing American lives

r/biotech user u/GoldStandardNIHilism posted that old, generic staple drugs such as basic anticancer medications are concentrated in single manufacturing sites in China/India, so if a site halts production there are prolonged shortages, while moving new production lines back to the US would require years of investment. In the comments, u/Biotruthologist asked where the funding and talent would come from; u/unblockedlanternhead and u/Ponji76 argued that US labor costs make domestic generic drug production uneconomical most of the time; u/throwaway3113151 proposed government strategic stockpiles as a backstop. The discussion reflects the structural fragility of a highly offshored generic drug supply chain with insufficient safety redundancy. On the factual level: the FDA does maintain a drug shortage list, and reliance of critical generics on a few overseas manufacturing sites is a real industry background; however, the OP did not cite specific shortage drugs or data, so this is policy discussion rather than quantified fact, and the relevant claims should be checked against the FDA shortage database and CMC capacity reports.

Checked 🔗 (FDA drug shortage list and offshored concentration of generics are real industry background; the OP did not list specific drugs/data — this is a policy discussion).